HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of macular subretinal neovascularization with the red-light krypton laser in presumed ocular histoplasmosis syndrome.

Abstract
A patient with presumed ocular histoplasmosis and decreased visual acuity in one eye had subretinal neovascularization and retinal hemorrhage in the macular area. Argon-laser treatment to eradicate the subretinal neovascular membrane was contraindicated because of the proximity of the hemorrhagic lesion to the fovea. We used a red-light krypton laser (647 nm) because the light is not absorbed by the hemoglobin in the retinal hemorrhage or by the macular luteal pigment (xanthophyll), and because it is transmitted into the choroid, allowing treatment within the macular zone with less damage to the internal retinal elements. After treatment, the subretinal neovascular membrane completely disappeared and the macular hemorrhage cleared. To the best of our knowledge, this is the first time that a histoplasmic macular subretinal neovascular membrane has been treated with the red-light krypton laser.
AuthorsY Yassur, E Gilad, I Ben-Sira
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 91 Issue 2 Pg. 172-6 (Feb 1981) ISSN: 0002-9394 [Print] United States
PMID6162387 (Publication Type: Case Reports, Journal Article)
Topics
  • Eye Diseases (diagnosis, surgery)
  • Female
  • Fluorescein Angiography
  • Histoplasmosis (diagnosis, surgery)
  • Humans
  • Laser Therapy
  • Lasers
  • Middle Aged
  • Neovascularization, Pathologic
  • Retinal Hemorrhage (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: